Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company BOERSE MUENCHEN

Equities

LLY

US5324571083

Real-time BOERSE MUENCHEN
Other stock markets
 20:14:15 05/07/2024 BST 		5-day change 1st Jan Change
843 EUR +1.31% Intraday chart for Eli Lilly and Company -1.99% +57.89%
07-04 ETF of the week: Investing in strong trends with the momentum theme Our Logo
07-03 Health Stocks Slip in Risk-On Trade -- Health Care Roundup DJ

Chart calendar Eli Lilly and Company

4defbcc02d310c7867061.NCQG2e_WTghRm9SsMtV4Dw2_XjcSfEyUdzbIQBT_Z2g.R3FxlL7nO3F81-D_SqxJSzjGElxmOnT2QwStOGGGACMAQzOXte4ZUhbxtw~1cd5367805238f6cf4a06b0f79f7e49d

Upcoming events on Eli Lilly and Company

08/08/2024 11:25 Q2 2024 Earnings Release
08/08/2024 15:00 Q2 2024 Earnings Call
30/10/2024 10:25 Q3 2024 Earnings Release
30/10/2024 14:00 Q3 2024 Earnings Call
29/01/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
04/08/2025 Q2 2025 Earnings Release (Projected)
03/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

21/06/2024 20:45 American Diabetes Association Scientific Symposium
10/06/2024 21:00 Goldman Sachs Global Healthcare Conference - Fireside Chat
03/06/2024 23:12 American Society of Clinical Oncology Meeting - Abstract Number: LBA507
03/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract Number: 8547
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 5589
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 11111
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 11068
03/06/2024 01:30 American Society of Clinical Oncology Meeting
02/06/2024 23:06 American Society of Clinical Oncology Meeting - Abstract Number: 10022
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 1027
01/06/2024 23:00 American Society of Clinical Oncology Meeting - Abstract Number: 3007
01/06/2024 21:12 American Society of Clinical Oncology Meeting - Abstract Number: 5001
01/06/2024 21:00 American Society of Clinical Oncology Meeting - Abstract Number: LBA1001
01/06/2024 19:39 American Society of Clinical Oncology Meeting - Abstract Number: 8510
01/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 3150
14/05/2024 Détachement de
06/05/2024 13:30 Annual General Meeting
30/04/2024 15:00 Q1 2024 Earnings Call
30/04/2024 11:45 Q1 2024 Earnings Release
08/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 3230

Past dividends on Eli Lilly and Company

14/05/2024 Quarterly 1.3 USD
13/02/2024 Quarterly 1.3 USD
13/11/2023 Quarterly 1.13 USD
13/08/2023 Quarterly 1.13 USD
11/05/2023 Quarterly 1.13 USD
13/02/2023 Quarterly 1.13 USD
13/11/2022 Quarterly 0.98 USD
11/08/2022 Quarterly 0.98 USD
12/05/2022 Quarterly 0.98 USD
13/02/2022 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 320
22 142
0.8%		24 540
24 394
0.6%		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
42 974

EBITDA
Million USD		Released
Forecast
Spread 		7 551
7 508
0.57%		8 589
8 676
-1.01%		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
16 230

EBIT
Million USD		Released
Forecast
Spread 		6 079
6 106
-0.44%		7 265
7 503
-3.17%		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
14 684

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 266
8 975
-41.33%		7 230
7 041
2.68%		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
13 749

Net income
Million USD		Released
Forecast
Spread 		8 318
8 090
2.83%		6 194
5 805
6.69%		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
11 932

EPS
USD		Released
Forecast
Spread 		8,89
8,65
2.83%		6,79
6,36
6.69%		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		7 810
7 319
6.7%		6 488
6 854
-5.33%		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%
10 001


11 344


12 784


10 920


12 135

EBITDA
Million USD		Released
Forecast
Spread 		3 046
2 717
12.12%		1 679
2 387
-29.67%		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%
3 750


4 844


5 994







EBIT
Million USD		Released
Forecast
Spread 		2 610
2 336
11.74%		1 330
1 790
-25.7%		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%
3 082


3 979


4 795







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread














2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%
3 000


3 878


4 497







Net income
Million USD		Released
Forecast
Spread 		1 903
1 711
11.22%		953
1 133
-15.93%		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%
2 477


3 249


4 025







EPS
USD		Released
Forecast
Spread


1,05
1,85
-43.24%		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%
2,77


3,60


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Upcoming sector events for Eli Lilly and Company

10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 11:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 DR. REDDY'S LABORATORIES LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
21/06/2024 16:28 DEVA HOLDING: Q1 2024 Earnings Release
13/06/2024 22:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 06:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 11:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 10:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LLY Stock
  5. Calendar Eli Lilly and Company